Checchi Capital Advisers LLC Cuts Holdings in Omega Healthcare Investors, Inc. $OHI

Checchi Capital Advisers LLC lowered its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 23.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,586 shares of the real estate investment trust’s stock after selling 2,696 shares during the period. Checchi Capital Advisers LLC’s holdings in Omega Healthcare Investors were worth $315,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. NBC Securities Inc. purchased a new stake in shares of Omega Healthcare Investors during the first quarter worth approximately $29,000. MassMutual Private Wealth & Trust FSB increased its position in shares of Omega Healthcare Investors by 562.3% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,828 shares of the real estate investment trust’s stock valued at $67,000 after purchasing an additional 1,552 shares during the last quarter. Register Financial Advisors LLC purchased a new stake in shares of Omega Healthcare Investors in the 2nd quarter valued at approximately $73,000. UMB Bank n.a. raised its holdings in shares of Omega Healthcare Investors by 94.9% in the 1st quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust’s stock valued at $83,000 after purchasing an additional 1,059 shares in the last quarter. Finally, Trust Co. of Vermont purchased a new stake in shares of Omega Healthcare Investors during the 2nd quarter worth $95,000. 65.25% of the stock is currently owned by hedge funds and other institutional investors.

Omega Healthcare Investors Trading Down 0.6%

NYSE:OHI opened at $40.90 on Tuesday. The company has a market capitalization of $12.07 billion, a PE ratio of 25.25, a P/E/G ratio of 2.15 and a beta of 0.70. Omega Healthcare Investors, Inc. has a 52-week low of $35.04 and a 52-week high of $44.42. The stock’s 50 day moving average price is $41.48 and its 200 day moving average price is $38.74. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.32. The business had revenue of $235.60 million during the quarter, compared to the consensus estimate of $248.49 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The company’s revenue was up 11.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, research analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.

Omega Healthcare Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were given a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 6.6%. The ex-dividend date of this dividend was Monday, August 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 165.43%.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. Weiss Ratings reissued a “buy (b)” rating on shares of Omega Healthcare Investors in a report on Saturday, September 27th. Raymond James Financial reiterated an “outperform” rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd. Wells Fargo & Company increased their price objective on Omega Healthcare Investors from $41.00 to $44.00 and gave the company an “overweight” rating in a report on Wednesday, August 27th. Truist Financial boosted their target price on Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a “hold” rating in a research note on Wednesday, September 3rd. Finally, Mizuho increased their price target on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a “neutral” rating in a research note on Thursday, September 11th. Seven analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $44.44.

Insider Buying and Selling

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the company’s stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the sale, the director directly owned 18,654 shares of the company’s stock, valued at approximately $749,144.64. This represents a 11.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.50% of the company’s stock.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.